Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption

https://doi.org/10.1016/S0169-409X(97)00497-3Get rights and content

Abstract

Oral bioavailability requires absorption of drugs across the intestinal epithelium. This may be mediated by either the paracellular and/or transcellular routes. Passive transcellular absorption requires the appropriate physicochemical properties to allow permeation across the apical and basolateral membrane domains. Compounds demonstrating these properties are more likely to be recognised as substrates for intracellular metabolism, such as by cytochrome P450 isozymes, and/or secretory drug efflux systems, including P-glycoprotein, such that oral bioavailability will be limited. P-glycoprotein, which leads to multidrug resistance in tumour cells, is an ATP-dependent secretory drug efflux pump, encoded by the MDR1 gene in humans. It acts to clear the membrane lipid bilayer of lipophilic drugs, in the manner of a flippase. In the intestine, as well as at specific other epithelial and endothelial sites, P-glycoprotein expression is localised to the apical membrane, consistent with secretory detoxifying and absorption limitation functions. Other secretory efflux systems, such as multidrug-resistance associated protein (a glutathione S-conjugate transporter), fluorochrome efflux systems and the methotrexate efflux system, together with drug ionic charge and the intestinal pH microclimate, may mediate intestinal secretion of a wide variety of drugs. Direct evidence for P-glycoprotein limiting drug absorption comes from studies in vitro with human Caco-2 cells and includes non-linear dependence of absorption on substrate (vinblastine) concentration, increased absorption upon saturation of secretion and increased absorption upon inhibition of P-glycoprotein function, with modulators such as verapamil. P-glycoprotein-like mechanisms are implicated in the intestinal secretion of a variety of drugs, in addition to classical P-glycoprotein substrates, including cyclosporin, certain peptides, digoxin, fluoroquinolones, ranitidine and β-adrenoceptor antagonists. These drug interactions with P-glycoprotein may explain the pharmacokinetics of absorption in vivo. P-glycoprotein function may be integrated with drug metabolism, with several drugs being common substrates for P-glycoprotein and cytochrome P-450 3A. Recognising the interactions of drugs with intestinal secretory and metabolic systems that limit absorption will lead to novel strategies of overcoming problems of poor oral bioavailability.

References (192)

  • W.T. Beck et al.

    Photoaffinity substrates for P-glycoprotein

    Biochem. Pharmacol.

    (1992)
  • S. Ruetz et al.

    Functional expression of P-glycoprotein in secretory vesicles

    J. Biol. Chem.

    (1994)
  • M.M. Cornwell et al.

    Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells

    J. Biol. Chem.

    (1986)
  • M. Horio et al.

    Agents which reverse multidrug resistance are in-hibitors of vinblastine transport by isolated vesicles

    Biochim. Biophys. Acta

    (1991)
  • M. Horio et al.

    Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia

    J. Biol. Chem.

    (1989)
  • A.M. Shimabuku et al.

    P-glycoprotein. ATP hydrolysis by the N-terminal nucleotide-binding domain

    J. Biol. Chem.

    (1992)
  • B. Sarkadi et al.

    Expression of the human multi-drug-resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase

    J. Biol. Chem.

    (1992)
  • Y. Raviv et al.

    Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells

    J. Biol. Chem.

    (1990)
  • C.F. Higgins et al.

    Is the multidrug transporter a flippase?

    Trends Biochem. Sci.

    (1992)
  • F.A. Sinicrope et al.

    Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles

    J. Biol. Chem.

    (1992)
  • P.R. Twentyman et al.

    Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance

    Eur. J. Cancer

    (1996)
  • I. Leier et al.

    The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates

    J. Biol. Chem.

    (1994)
  • T. Ishikawa

    The ATP-dependent glutathione S-conjugate export pump

    Trends Biochem. Sci.

    (1992)
  • M.T. Vincenzini et al.

    Intestinal uptake and transmembrane transport systems of intact GSH; characteristics and possible biological role

    Biochim. Biophys. Acta

    (1992)
  • C.N. Allen et al.

    Efflux of bis-carboxyethyl-carboxyfluorescein (BCECF) by a novel ATP-dependent transport mechanism in epithelial cells

    Biochem. Biophys. Res. Commun.

    (1990)
  • G. Liminga et al.

    Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833

    Exp. Cell Res.

    (1994)
  • D.M. Wall et al.

    Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, Fluo-3

    Eur. J. Cancer

    (1993)
  • J. Selhub et al.

    Gastrointestinal absorption of folates and antifolates

    Pharmacol. Ther.

    (1983)
  • J. Zimmerman

    Methotrexate transport in the human intestine

    Biochem. Pharmacol.

    (1992)
  • J. Zimmerman

    Folic acid transport in organ-cultured mucosa of human intestine. Evidence for distinct carriers

    Gastroenterology

    (1990)
  • K. Simons et al.

    Cell surface polarity in epithelia

    Ann. Rev. Cell Biol.

    (1985)
  • I. Bjarnson et al.

    Intestinal permeability: an overview

    Gastroenterology

    (1995)
  • C.S. Tidball

    The nature of the intestinal barrier

    Dig. Dis.

    (1971)
  • C.B. Collares-Buzato et al.

    Junctional uvomorulin/E-cadherin and phosphotyrosine-modified protein content are correlated with the paracellular permeability in Madin-Darby canine kidney (MDCK) epithelia

    Histochemistry

    (1994)
  • P.G. Dayton et al.

    Elimination of drugs by passive diffusion from blood to intestinal lumen: factors influencing nonbiliary excretion by the intestinal tract

    Drug Metab. Rev.

    (1983)
  • Z.H. Israili et al.

    Enhancement of xenobiotic elimination: role of intestinal excretion

    Drug Metab. Rev.

    (1984)
  • T.T. Kararli

    Gastrointestinal absorption of drugs

    Crit. Rev. Ther. Drug Carrier Syst.

    (1989)
  • W.R. Lieb et al.

    Implications of two different types of diffusion for biological membranes

    Nature New Biol.

    (1971)
  • N.R. Hartman et al.

    Pharmacokinetics of 2′,3′-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effect of different oral formulations and the presence of other medications

    Clin. Pharmacol. Ther.

    (1991)
  • H.P. Illing

    Techniques for microfloral and associated metabolic studies in relation to the absorption and enterohepatic circulation of drugs

    Xenobiotica

    (1981)
  • K. Hartiala

    Metabolism of hormones, drugs and other substances by the gut

    Physiol. Rev.

    (1973)
  • K.M. Hillgren et al.

    In vitro systems for studying intestinal drug absorption

    Med. Res. Rev.

    (1995)
  • J. Hunter et al.

    Transepithelial vinblastine secretion mediated by P-glycoprotein is inhibited by forskolin derivatives

    Biochem. Biophys. Res. Commun.

    (1991)
  • N.M. Griffiths et al.

    Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers

    Br. J. Pharmacol.

    (1993)
  • D.C. Kim et al.

    Evaluation of the bile acid transporter in enhancing intestinal permeability to renin-inhibitory peptides

    J. Drug Targeting

    (1993)
  • M. Hu et al.

    Mechanism of l-alphamethyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2)

    Pharm. Res.

    (1990)
  • D.T. Thwaites et al.

    d-Cycloserine transport in human intestinal (Caco-2) cells: mediation by a H+-coupled amino acid transporter

    Br. J. Pharmacol.

    (1995)
  • K. Inui et al.

    Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes

    J. Pharmacol. Exp. Ther.

    (1992)
  • H. Saitoh et al.

    Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine

    Pharm. Res.

    (1995)
  • I.J. Hidalgo et al.

    Structural requirements for interaction with oligopeptide transporter in Caco-2 cells

    Pharm. Res.

    (1995)
  • Cited by (0)

    View full text